85
Views
8
CrossRef citations to date
0
Altmetric
Article

Combined gamma‐irradiation and subsequent cisplatin treatment in human squamous carcinoma cell lines sensitive and resistant to cisplatin

, , &
Pages 291-299 | Received 12 Mar 2003, Accepted 04 Dec 2003, Published online: 03 Jul 2009

References

  • AL-SARRAF, M., 1984, Chemotherapeutic strategies in squamous cell carcinoma of the head and neck. CRC Critical Reviews in Oncology and Hematology, 1, 323–355.
  • BECK-BORNHOLDT, H., MAURER, T., BECKER, S., OMNICZYMSKI, M., VOGLER, H. and WURSCHMTDT, F., 1989, Radiotherapy of the rhabdomyosarcoma R1H of the rat: hyperfractionation-126 fractions applied within 6 weeks. International Journal of Radiation Oncology Biology Physics, 16, 701–705.
  • BEGG, A., VAN DER KOLK, H. and DEWIT, L., 1986, Racliosensitization by cisplatin of Rifl tumor cells in vitro. International Journal of Radiation Biology, 50, 871–884.
  • BEVINGTON, P., 1969, Data Reduction and Error Analysis for the Physical Sciences (New York: McGraw-Hill).
  • BLANKE, C., MANTRAVADI, R. and ANSARI, R., 1995, Phase III trial of thoracic irradiation with or without cisplatin for locally unresectable non-small-cell lung cancer: an oncology group protocol. Journal of Clinical Oncology, 13, 1425–1429.
  • CANEY, C. M., BULMER, J. T., SINGH, G., LUKKA, H. and RAINBOW, A. J., 1999, Pre-exposure of human squamous carcinoma cells to low-doses of gamma-rays leads to an increased resistance to subsequent low-dose cisplatin treatment. International Journal of Radiation Biology, 75, 963–972.
  • GARDE, P. and LAVAL, F., 1981, Effect of cis-diamminedichloroplatinum(II) and X rays on mammalian cell survival. International Journal of Radiation Oncology Biology Physics, 7, 929–933.
  • CHANDNA, S., DWARAKANATH, B. S., KHAITAN, D., MATHEW, T. L. and JAIN, V., 2002, Low-dose radiation hypersensitivity in human tumor cell lines: effects of cell—cell contact and nutritional deprivation. Radiation Research, 157, 516–525.
  • CRISSMAN, J., PAJAK, T., ZARBO, R., MARCIAL, V. and AL-SARRAF, M., 1987, Improved response and survival to combined cisplatin and radiation in non-keratinizing squamous cell carcinoma of the head and neck. Cancer, 59, 1391–1397.
  • DEMPKE, W. C. M., SHELLARD, S. A., HUSKING, L. K., FICHTINGER-SCHEPMAN, A. M. J. and HILL, B. T., 1992, Mechanisms associated with the expression of cisplatin resistance in a human ovarian tumor cell line following exposure to fractionated X-irradiation in vitro. Carcinogenesis, 13, 1209–1215.
  • DEWIT, L., 1987, Combination treatment of radiation and cis-diamminedichloroplatinum(II): a review of experimental and clinical data. International Journal of Radiation Oncology Biology Physics, 13, 403–426.
  • DOLLING, J.-A., BOREHAM, D. R., BROWN, D. L., MrrcHEL, R. E. and RAAPHORST, G. P., 1998, Modulation of radiation-induced strand break repair by cisplatin in mammalian cells. International Journal of Radiation Biology, 74, 61–69.
  • DURAND, R., 1986, Use of a cell sorter for assays of cell clonogenicity. Cancer Research, 46, 2775–2778.
  • EICITHOLTZ-WIRTH, H. and HIETEL, B., 1994, Cisplatin resistance in mouse fibrosarcoma cells after low-dose irradiation in vitro and in vivo. British Journal of Cancer, 70, 579–584.
  • EICITHOLTZ-WIRTH, H., REIDEL, G. and HIETEL, B., 1993, Radiation-induced transient cisplatin resistance in murine fibrosarcoma cells associated with elevated metallothionein content. British Journal of Cancer, 67, 1001–1006.
  • HAZUKA, M., CROWLEY, J. and Bum, P., 1994, Daily low-dose cisplatin plus concurrent high-dose thoracic irradiation in locally advanced unresectable non-small-cell lung cancer: results of a phase II oncology group study. Journal of Clinical Oncology, 12, 1814–1820.
  • HILL, B. T., SHELLARD, S. A., HSKING, L. K., FICHTINGER-SCHEPMAN, A. M. J. and BEDFORD, P., 1990, Enhanced DNA repair and tolerance of DNA damage associated with resistance to cis-cliammine-dichloroplatinum (II) after in vitro exposure of a human teratoma cell line to fractionated x-irradiation. International Journal of Radiation Oncology, 19, 75–83.
  • JEGGO, P. A., 1998, Identification of genes involved in repair of double-strand breaks in mammalian cells. Radiation Research, 150, S80—S91.
  • JOINER, M. C., 1994, Induced radioresistance: an overview and historical perspective. International Journal of Radiation Biology, 65, 79–84.
  • JOINER, M. C., MARPLES, B., LAMBIN, P., SHORT, S. C. and TURESSON, I., 2001, Low-dose hypersensitivity: current status and possible mechanisms. International Journal of Radiation Oncology Biology Physics, 49, 379–389.
  • KORBELIK, M. and SKov, K. A., 1989, Inactivation of hypoxic cells by cisplatin and radiation at clinically relevant doses. Radiation Research, 119, 145–156.
  • LAMBIN, P., MALAISE, E. and JOINER, M. C., 1994, The effect of very low radiation doses on the human bladder carcinoma cell line RT112. Radiotherapy and Oncology, 32, 63–72.
  • LAMBIN, P., MARPLES, B., FERTIL, B., MALAISE, E. and JOINER, M. C., 1993, Hypersensitivity of a human tumor cell line to very low dose radiation. International Journal of Radiation Biology, 63, 639–650.
  • LE, X. C., XE\TG, J. Z., LEE, J. Z., LEADON, S. A. and WEINFELD, M., 1998, Inducible repair of thymine glycols detected by an ultrasensitive assay for DNA damage. Science, 280, 1066–1069.
  • LUSTIG, A. J., 1999, The kudos of non-homologous end-joining. Nature Genetics, 23, 130–131.
  • MARPLES, B., ADOMAT, H., Kocx, C. and SKov, K. A., 1996, Response of V79 cells to low doses of X-rays and negative pi-mesons: clonogenic survival and DNA strand breaks. International Journal of Radiation Biology, 70, 429–436.
  • MARPLES, B., CANN, N. E., MucHELL, C. R., JOHNSTON, P. J. and JOINER, M. C., 2002, Evidence for the involvement of DNA-dependent protein kinase in the phenomena of low dose hypersensitivity of low dose hyper-racliosensitivity and increased radioresistance. International Journal of Radiation Biology, 78, 1139–1147.
  • MARPLES, B. and JOINER, M. C., 1993, The response of Chinese hamster cells at low radiation doses: evidence of enhanced sensitivity of the whole cell population. Radiation Research, 133, 41–51.
  • MARPLES, B. and JOINER, M. C., 1995, The elimination of low-dose hypersensitivity in V79-379A cells by pre-treatment with X-rays or hydrogen peroxide. Radiation Research, 141, 160–169.
  • MARPLES, B. and JOINER, M. C., 2000, Modification of survival by DNA repair modifiers: a probable explanation for the phenomenon of increased radioresistance. International Journal of Radiation Biology, 76, 305–312.
  • MARPLES, B., LAMBIN, P., SKov, K. A. and JOINER, M. C., 1997, Low dose hyper-racliosensitivity and increased radioresistance in mammalian cells. International Journal of Radiation Biology, 71, 721–735.
  • MARPLES, B. and SKov, K. A., 1996, Small doses of high-linear energy transfer radiation increase the radioresistance of Chinese hamster V79 cells to subsequent X irradiation. Radiation Research, 146, 369–374.
  • MILAS, L., MASON, K. A. LIAO Z. and ANG, K. K., 2003, Chemoracliotherapy: emerging treatment improvement strategies. Head and Neck, 25, 152–167.
  • MYINT, W. K., NG, C. and RAAPHORST, G. P., 2002, Examining the non-homologous repair process following cisplatin and radiation treatments. International Journal of Radiation Biology, 78, 417–424.
  • NAKAMOTO, S., MnsullAsm, N., TAKAHASHI, T., SAKURAI, H. and NIEBE, H., 1996, An interaction of cisplatin and radiation in two rat yolk sac tumor cell lines with different radiosensitivities in vitro. International Journal of Radiation Biology, 70, 747–753.
  • PALCIC, B. and JAGGI, B., 1986, The use of solid state sensor technology to detect and characterize live mammalian cells growing in tissue culture. International Journal of Radiation Biology, 50, 345–352.
  • RAAPHORST, G. P., CYBuLsxr, S. E., SosoL, R. and NG, C. E., 2001, The response of human breast tumour cell lines with altered polymerase beta levels to cisplatin and radiation. Anticancer Research, 21, 2079–2083.
  • RAAPHORST, G. P., WANG, S., STEWART, D. and NG, C., 1996, Concomitant low dose-rate irradiation and cisplatin treatment in ovarian carcinoma cell lines sensitive and resistant to cisplatin treatment. International Journal of Radiation Biology, 69, 623–631.
  • RAAPHORST, G. P., WIIKINTs, D. E., MAO, J. P., MIAO, J. C. and NG, C. E., 1999, Evaluation of cross resistance between responses to cisplatin, hyperthermia, and radiation in human glioma cells and eight clones selected for cisplatin resistance. Radiation Oncology Investigations, 7, 153–157.
  • SCHAAKE-KONING, C., VAN DEN BOGAERT, W., DALESIO, 0., FESTEN, J., HOOGENHOUT, J., VAN HOUTTE, P., KIRKPATRICK, A., KOOLEN, M., MT, B. and Nus, A., 1994, Radio-sensitization by cytotoxic drugs. The EORTC experience by the Radiotherapy and Lung Cancer Cooperative Groups. Lung Cancer, 10 (Suppl. 1), 5263–5270.
  • SCHEFLER, W., 1988, Statistics: Concepts and Applications (Don Mills: Benjamin/Cummings).
  • SHORT, S. C., WOODCOCK, M., MARPLES, B. and JOIN, M., 2003, Effects of cell cycle phase on low-dose hypersensitivity. International Journal of Radiation Biology, 79, 99–105.
  • SINGH, B., ARRAND, J. E. and JoINER, M. C., 1994, Hypersensitive response of normal human lung epithelial cells at low radiation doses. International Journal of Radiation Biology, 65, 457–464.
  • SKARSGARD, L. D., HARRISON, I. and DURAND, R., 1991, The radia-tion response of asychronous cells at low dose: evidence for substructure. Radiation Research, 127, 248–256.
  • SKOV, K. A., 1999, Perspectives on the adaptive response from studies on the response to low radiation doses (or to cisplatin) in mammalian cells. Human and Experimental Toxicology, 18, 447–451.
  • SKOV, K. A. and MACPHAIL, S., 1991, Interaction of platinum drugs with clinically relevant X-ray doses in mammalian cells: a comparison of cisplatin, carboplatin, iproplatin and tetraplatin. International Journal of Radiation Oncology Biology Physics, 20, 221–225.
  • SKOV, K. A., MACPHAIL, S. and MARPLES, B., 1994a, The effect of radiosensitizers on the survival response of hypoxic mammalian cells: the low x-ray dose region, hypersensitivity and induced resistance. Radiation Research, 138, S113—S116.
  • SKOV, K. A. and MARPLES, B., 1995, Increased radioresistance at clinical doses: investigations from the survival perspective. Radiation Oncology Investigations, 2, 201–211.
  • SKOV, K. A., MARPLES, B., MATHEWS, J. B., JOINER, M. C. and Zuou, H., 1994b, A preliminary investigation into the extent of increased raclioresistance or hyper-racliosensitivity in cells of hamster cell lines known to be deficient in DNA repair. Radiation Research, 138, s126—s129.
  • SPADINGER, I. and PALCIC, B., 1993, Cell survival measurements at low doses using an automated image cytometry device. International Journal of Radiation Biology, 63, 183–189.
  • STEWART, D., MOLEPO, J. and EAPEN, L., 1994, Cisplatin and radiation in the treatment of tumors of the central nervous system: a review. International Journal of Radiation Oncology Biology Physics, 28, 531–542.
  • TEICHER, B., HOLDEN, S. and KELLEY, M., 1987, Characterization of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum(II). Cancer Research, 47, 388–393.
  • VAGANAYJUERY, S., MULLER, C., MARANGONI, E., ABDULKARIIVI, B., SALLES, B., JOINER, M. and BOURHIS, J., 2000, Decreased DNA-PK activity in human cancer cells exhibiting hypersensitivity to low-dose irradiation. British Journal of Cancer, 83, 514–518.
  • WALTER, P., KORBELIK, M., SPADINGER, I. and SKov, K. A., 1993, Investigations into mechanisms of the interaction between platinum complexes and irradiation at low ( --, 2 Gy) doses in hypoxic cells: role of single-strand breaks. Radiation Oncology Investigations, 1, 137–147.
  • WHEELER, R. H. and SPENCER, S., 1995, Cisplatin plus radiation therapy. Journal of Infusional Chemotherapy, 5, 61–66.
  • WILKINS, D., HELLER, D. and RAAPHORST, G. P., 1993, Inhibition of potentially lethal damage recovery by cisplatin in the 9L rat brain cell line. Anticancer Research, 13, 2137–2142.
  • WILKINS, D., NG, C. E. and RAAPHORST, G. P., 1996, Cisplatin and low dose rate irradiation in cisplatin resistant and sensitive human glioma cells. International Journal of Radiation Oncology Biology Physics, 36, 105–111.
  • WOUTERS, S. and SKARSGARD, L., 1996, Low dose hypersensitivity and increased raclioresistance in a panel of human tumor cell lines with different racliosensitivity. Radiation Research, 146, 399–413.
  • WU, X. and LIEBER, M. R., 1996, Protein—protein and protein—DNA interaction regions within the DNA end-binding protein Ku70—Ku86. Molecular and Cellular Biology, 16, 5186–5195.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.